Zenas BioPharma Inc. (ZBIO)
NASDAQ: ZBIO
· Real-Time Price · USD
16.82
0.06 (0.36%)
At close: Aug 15, 2025, 3:59 PM
17.00
1.07%
After-hours: Aug 15, 2025, 05:40 PM EDT
Zenas BioPharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 44.01M | 196.55M | 319.74M | 360.04M | 183.93M | 37.15M | 56.86M | 72.31M | n/a | 67.21M |
Short-Term Investments | 229.27M | 115.83M | 31.02M | 26.76M | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 1.61M | 1.83M | n/a | n/a | 88K | 86K | 86K | n/a | n/a | n/a |
Other Long-Term Assets | 11.8M | 12.85M | 12.86M | 9.11M | 10.56M | 8.41M | 7.28M | 5.97M | -67.21M | 4.33M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.32M | 5.43M | 5.16M | 6.98M | 4.67M | 2.55M | 2.95M | n/a | n/a | 1.24M |
Total Current Assets | 278.6M | 317.81M | 355.92M | 393.78M | 188.6M | 39.7M | 59.8M | 76.68M | 67.21M | 68.44M |
Property-Plant & Equipment | 1.07M | 1.28M | 1.19M | 545K | 706K | 847K | 1.01M | 1.15M | n/a | 1.8M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 14.48M | 15.96M | 14.04M | 9.65M | 11.35M | 9.35M | 8.38M | 7.12M | -67.21M | 6.13M |
Total Assets | 293.08M | 333.77M | 369.97M | 403.43M | 199.95M | 49.05M | 68.18M | 83.79M | n/a | 74.58M |
Account Payables | 7.93M | 20.02M | 17.14M | 15.08M | 8.36M | 8.83M | 5.4M | 2.28M | n/a | 5.82M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 793K | 908K | 785K | 384K | 494K | 516K | 556K | n/a | n/a | n/a |
Other Current Liabilities | 38.47M | 2.48M | 7.52M | 5.8M | 3.88M | 3.21M | 4.57M | 4.12M | n/a | 4.33M |
Total Current Liabilities | 53.24M | 49.13M | 57.29M | 44M | 39.11M | 30.33M | 23.26M | 15.56M | n/a | 25.97M |
Long-Term Debt | 215K | n/a | n/a | n/a | n/a | 20.99M | 20.3M | 20M | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 449.61M | 250.09M | 250.09M | 250.09M | -47.8M | 240.09M |
Total Long-Term Liabilities | 215K | 317K | 218K | n/a | 449.63M | 271.21M | 270.64M | 270.47M | -47.8M | 240.9M |
Total Liabilities | 53.46M | 49.45M | 57.51M | 44M | 488.73M | 301.55M | 293.9M | 286.02M | -47.8M | 266.87M |
Total Debt | 1.01M | 1.23M | 1M | 384K | 508K | 21.64M | 21.11M | 20.96M | n/a | 1.53M |
Common Stock | 4K | 4K | 4K | 4K | 1K | 1K | 1K | 1K | n/a | n/a |
Retained Earnings | -473.19M | -420.96M | -387.39M | -334.79M | -296.18M | -258.2M | -230.4M | -205.82M | n/a | -193.28M |
Comprehensive Income | -94K | 141K | 194K | 54K | 104K | 74K | 37K | 124K | -192.29M | -41K |
Shareholders Equity | 239.63M | 284.32M | 312.46M | 359.44M | -288.78M | -252.5M | -225.72M | -202.23M | 47.8M | -192.29M |
Total Investments | 230.89M | 117.66M | 31.02M | 26.76M | 88K | 86K | 86K | n/a | n/a | n/a |